CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −14,622 | 8,582 | ||
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −1,000 | 0 | ||
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −1,166 | 0 | ||
| 2014-02-12 | Sharp John P VP Finance and CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −4,584 | 10,984 | ||
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Grant or award | +2,500 | 29,645 | ||
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +386 | $42.90 | $17K | 30,031 |
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −386 | $74.50 | $29K | 29,645 |
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +1,166 | $21.00 | $24K | 30,811 |
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −1,166 | $74.50 | $87K | 29,645 |
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +1,000 | $16.14 | $16K | 30,645 |
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −1,000 | $74.50 | $75K | 29,645 |
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +4,584 | $21.92 | $100K | 34,229 |
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −4,584 | $74.50 | $342K | 29,645 |
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +4,779 | $10.05 | $48K | 34,424 |
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −4,779 | $74.50 | $356K | 29,645 |
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +1,230 | $14.47 | $18K | 30,875 |
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −1,230 | $74.50 | $92K | 29,645 |
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −1,736 | $74.50 | $129K | 27,909 |
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +1,736 | $9.96 | $17K | 29,645 |
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Employee Stock Option (right to buy) | −1,230 | 1,620 |
Page 78 of 86 · 1,712 trades